Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
7.54
+0.74 (10.88%)
At close: Feb 27, 2026, 4:00 PM EST
7.41
-0.13 (-1.76%)
After-hours: Feb 27, 2026, 7:33 PM EST

Rallybio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
404090249307-
Market Cap Growth
32.37%-55.91%-63.67%-18.90%--
Enterprise Value
-19-35-31117120-
Last Close Price
7.547.6819.1252.5676.32-
PS Ratio
59.0762.62----
PB Ratio
0.630.650.851.471.75-
P/TBV Ratio
0.630.650.851.471.75-
Debt / Equity Ratio
0.000.000.000.00--
Net Debt / Equity Ratio
-0.94-1.06-1.03-0.99-1.00-1.03
Net Debt / EBITDA Ratio
1.781.151.392.493.855.56
Net Debt / FCF Ratio
1.691.331.822.943.826.32
Asset Turnover
0.010.01----
Quick Ratio
13.1310.5011.8715.7326.7624.00
Current Ratio
14.7410.8712.3916.7127.6124.18
Return on Equity (ROE)
-21.17%-68.85%-54.13%-38.65%-30.18%-34.60%
Return on Assets (ROA)
-28.35%-38.91%-33.33%-23.40%-17.61%-19.35%
Return on Capital Employed (ROCE)
-52.70%-92.50%-74.20%-40.00%-26.00%-18.60%
Earnings Yield
-35.59%-145.06%-82.55%-26.81%-15.34%-
FCF Yield
-87.90%-123.74%-66.73%-23.06%-14.96%-
Buyback Yield / Dilution
-5.40%-7.66%-27.11%-24.70%-46.76%-913.79%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q